Felix Doss

Felix Doss currently serves as a senior leader within Novartis’s Corporate Finance division, where he leverages his extensive expertise in financial management, strategic planning, and operational excellence to drive the company’s financial health and sustainable growth. In his role, Felix oversees complex financial reporting, management consultancy initiatives, and CFO services, ensuring alignment with Novartis’s global business objectives. His deep understanding of accounting standards, internal audit processes, and compliance frameworks enables him to design and implement robust operational controls that mitigate risks and enhance financial integrity across diverse markets.

Felix’s key projects often involve developing progressive business plans that support innovative drug development pipelines and market expansion strategies. His proficiency in forecasting and financial analysis allows him to provide actionable insights that inform critical decision-making at the executive level. With a proven track record of leading cross-functional and multicultural teams, Felix excels in fostering collaborative environments that promote continuous improvement and operational efficiency. His leadership in finance transformation initiatives has been instrumental in streamlining reporting processes and enhancing data accuracy, thereby supporting Novartis’s commitment to transparency and regulatory compliance.

With a keen interest in challenging environments, Felix thrives in growth-oriented settings where strategic agility and financial discipline are paramount. His core competencies in corporate finance, internal audit, and management consultancy, combined with his people skills, position him as a trusted advisor and a driving force behind Novartis’s financial excellence. Felix’s ability to navigate complex financial landscapes and lead diverse teams underscores his value as a leader in the pharmaceutical industry’s dynamic and highly regulated environment.